Pharmacokinetics, Biodistribution, and Radiation Dosimetry for (89)Zr-Trastuzumab in Patients with Esophagogastric Cancer

Trastuzumab with chemotherapy improves clinical outcomes in patients with human epidermal growth factor receptor 2 (HER2)–positive esophagogastric adenocarcinoma (EGA). Despite the therapeutic benefit, responses are rarely complete, and most patients develop progression. To our knowledge, this is th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: O'Donoghue, Joseph A., Lewis, Jason S., Pandit-Taskar, Neeta, Fleming, Stephen E., Schöder, Heiko, Larson, Steven M., Beylergil, Volkan, Ruan, Shutian, Lyashchenko, Serge K., Zanzonico, Pat B., Weber, Wolfgang A., Carrasquillo, Jorge A., Janjigian, Yelena Y.
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2018
Assuntos:
Radiobiology/Dosimetry
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750520/
https://ncbi.nlm.nih.gov/pubmed/28637800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.194555
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados